A light and sound show of cancer therapy

Sharmistha Chatterjee

DOI: https://doi.org/10.1038/s42003-024-05900-8

IF: 6.548

2024-02-20

Communications Biology

Abstract:Nanoparticle therapy continues to be an attractive avenue of targeted and personalised therapies. A molecular nano-conjugate developed by Zeng et al. effectively targets cancer cells and aids in their diagnosis, therapy, and also optimises innate immune responses.

biology

What problem does this paper attempt to address?

The paper attempts to address the challenges in diagnosing and treating glioblastoma multiforme, a malignant brain tumor. Specifically, the researchers have developed a novel nanoparticle (PEG/αCD25-Cy7/TMZ) aimed at specifically targeting regulatory T cells (T-reg cells) in the tumor microenvironment through photoacoustic imaging technology, thereby enhancing the efficacy of immunotherapy.

### Main Issues:
1. **Immunosuppressive Effect of the Tumor Microenvironment**: The tumor microenvironment of glioblastoma contains a large number of regulatory T cells (T-reg cells), which suppress other immune cells (such as effector T cells, cytotoxic T cells, B cells, natural killer cells, and macrophages) from attacking cancer cells, leading to poor immunotherapy outcomes.
2. **Challenge of Specifically Eliminating T-reg Cells**: How to specifically eliminate T-reg cells in the tumor microenvironment without disrupting normal immune homeostasis is a long-standing challenge.
3. **Precision Diagnosis and Treatment**: Existing diagnostic methods (such as MRI and CT) have strong penetration but cannot provide sufficient resolution to accurately locate tumor cells and their microenvironment. Additionally, traditional treatment methods often lack specificity and have significant side effects.

### Solution:
- **Design of Nanoparticles**: Researchers designed a nanoparticle responsive to ultrasound-assisted laser irradiation (PEG/αCD25-Cy7/TMZ). This nanoparticle contains specific molecules (Cy7) that emit specific signals under photoacoustic imaging, used to precisely locate tumor cells.
- **Targeting T-reg Cells**: The nanoparticles are attached with antibodies targeting T-reg cells, which can specifically recognize and bind to these cells, achieving precise elimination of T-reg cells.
- **Drug Release Mechanism**: The nanoparticles respond to high concentrations of glutathione (GSH) in the tumor microenvironment, releasing the loaded anticancer drug temozolomide (TMZ) and the fluorescent molecule Cy7, thereby exerting anticancer effects locally.
- **Enhancing Immune Response**: By eliminating T-reg cells, the nanoparticles help enhance the activity of immunotherapy drugs (such as IDO inhibitors), making the tumor site more sensitive to attacks by other immune cells.

### Significance:
This study provides a new strategy for the precise diagnosis and treatment of glioblastoma, particularly through non-invasive diagnosis using photoacoustic imaging technology and enhancing the efficacy of immunotherapy by targeting T-reg cells. This not only helps improve treatment outcomes but also reduces the side effects of traditional treatment methods, with significant clinical application prospects.